NCT04834518View on ClinicalTrials.gov

Screening for Islet Autoantibodies in the Israeli Paediatric General Population for Detection of Pre-symptomatic Type-1 Diabetes Mellitus

RecruitingOBSERVATIONAL
Enrollment

50,000

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Type1diabetes
Trial Locations (7)

Unknown

RECRUITING

Soroka Medical Center, Beersheba

NOT_YET_RECRUITING

Rambam Medical Center, Haifa

NOT_YET_RECRUITING

Hadassah medical Center, Jerusalem

RECRUITING

Child Health Centers all over Israel (clalit Health Services), Petah Tikva

RECRUITING

Schneider Children Medical Center of Israel, Petah Tikva

NOT_YET_RECRUITING

Sheba Medical Center, Ramat Gan

NOT_YET_RECRUITING

Dana-Duek children's hospital, Tel Aviv

Sponsors
All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

Rabin Medical Center

OTHER